Prostate Cancer - Results from #28360

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC) - Abstract March 29, 2011

CURy 2011 - A multidisciplinary team approach to metastatic hormone-refractory prostate cancer treatment - Slide Presentation March 29, 2011

Researchers find many elderly men are undergoing unnecessary PSA screenings March 29, 2011

Use of testosterone replacement therapy in patients with prostate cancer - Abstract March 28, 2011

Prostate-specific antigen for treatment monitoring - Abstract March 28, 2011

The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy - Abstract March 28, 2011

Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy - Abstract March 28, 2011

Utilization and expense of adjuvant cancer therapies following radical prostatectomy - Abstract March 28, 2011

Steps in prostate cancer progression that lead to bone metastasis - Abstract March 28, 2011

Editor's Commentary - Factors that influence patient enrollment in active surveillance for low-risk prostate cancer March 28, 2011

Prostate cancer ablation with transrectal high-intensity focused ultrasound: Assessment of tissue destruction with contrast-enhanced US - Abstract March 25, 2011

Impact of comorbidity on survival among men with localized prostate cancer - Abstract March 25, 2011

Fatigue in prostate cancer patients treated with external beam radiotherapy: A prospective 5-year long-term patient-reported evaluation - Abstract March 25, 2011

Contemporary management of patients with T1a and T1b prostate cancer - Abstract March 25, 2011

Prostate cancer susceptibility loci identified on chromosome 12 in African Americans - Abstract March 25, 2011

Enhancing prostate cancer care through the multidisciplinary clinic approach: A 15-year experience - Abstract March 25, 2011

Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy - Abstract March 25, 2011

Gene expression pathways of high grade localized prostate cancer - Abstract March 25, 2011

Response to degarelix after resistance to luteinizing hormone-releasing hormone agonist therapy for metastatic prostate cancer - Abstract March 25, 2011

CURy 2011 - HIFU in low risk prostate cancer - Slide Presentation March 25, 2011

Page 1419 of 1436